Femasys (NASDAQ:FEMY) Trading 1.4% Higher – What’s Next?

Femasys Inc. (NASDAQ:FEMY) was up 1.4% during mid-day trading on Tuesday . The company traded as high as $0.5599 and last traded at $0.5234. Approximately 883,604 shares traded hands during mid-day trading, a decline of 14% from the average daily volume of 1,027,730 shares. The stock had previously closed at $0.5160.

Wall Street Analyst Weigh In

Several research analysts recently commented on FEMY shares. Weiss Ratings restated a “sell (e+)” rating on shares of Femasys in a report on Thursday, January 22nd. Laidlaw started coverage on shares of Femasys in a research note on Thursday, November 20th. They set a “buy” rating and a $6.50 price objective for the company. Finally, Wall Street Zen cut Femasys from a “hold” rating to a “sell” rating in a report on Saturday, December 20th. Three equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, Femasys presently has a consensus rating of “Moderate Buy” and an average price target of $6.83.

Femasys Stock Performance

The company has a fifty day moving average of $0.72 and a two-hundred day moving average of $0.67. The firm has a market capitalization of $30.61 million, a price-to-earnings ratio of -0.73 and a beta of -2.54. The company has a debt-to-equity ratio of 0.01, a quick ratio of 0.61 and a current ratio of 1.16.

Femasys (NASDAQ:FEMY) last issued its quarterly earnings data on Friday, November 14th. The company reported ($0.10) EPS for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.02. Femasys had a negative return on equity of 764.26% and a negative net margin of 960.80%.The firm had revenue of $0.73 million for the quarter, compared to analyst estimates of $1.35 million. As a group, equities research analysts predict that Femasys Inc. will post -0.86 earnings per share for the current fiscal year.

Institutional Trading of Femasys

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Clear Creek Financial Management LLC boosted its holdings in Femasys by 4.2% in the 2nd quarter. Clear Creek Financial Management LLC now owns 281,821 shares of the company’s stock valued at $272,000 after purchasing an additional 11,450 shares during the period. Osaic Holdings Inc. acquired a new stake in shares of Femasys in the second quarter valued at approximately $45,000. Finally, Jane Street Group LLC bought a new stake in shares of Femasys in the second quarter valued at approximately $82,000. Institutional investors and hedge funds own 65.27% of the company’s stock.

About Femasys

Femasys International, Inc is a medical device company focused on the research, development and commercialization of innovative technologies for interventional women’s health applications. The company’s core activities center on creating minimally invasive diagnostic and therapeutic products designed to address uterine cavity evaluation and treatment and to improve outcomes in gynecological care.

The company’s flagship product, the FemVue® hydrosonography system, is a single-use catheter-based device that enhances visualization of the uterine cavity through saline infusion sonography.